Are Litigation Finance Investments the Ultimate Diversification Tool?
As featured in this month’s Master Investor Magazine. “To reduce risk it is necessary to avoid a portfolio whose securities…
As featured in this month’s Master Investor Magazine. “To reduce risk it is necessary to avoid a portfolio whose securities…
GKN at 327p after last week’s good news on UK motor production figures... The GKN (Guest Keen & Nettlefold, as…
My brief analysis of the Greek war of Interdependence and what it means for equity markets. Even without the urging…
Microsoft changed our lives. I couldn’t have written this article without their technology, and you couldn’t read it. Some say…
Centrica (CNA): at 270p last seen. The technical chart position looks inviting. Clearly something has to be done to put…
The company is now generating a lot of cash and has attractive dividend paying prospects. Given that and the fact…
Chocolate – indulgence, gift, comfort food the world over. The sweet treat is many things to many people, and a…
Since launching the JIC Portfolio in January 2012 the portfolio is up 114.5% as of Friday 19th June 2015. I have…
As a precursor to my Final Word article in the main magazine next month, I've been examining the firearms market…
GlaxoSmithKline at 1370p. This company is undergoing considerable change in its strategic objectives. It looks attractive on both market consensus…